ATE270707T1 - Entepneumovirus und entsprechendes impfstoff - Google Patents

Entepneumovirus und entsprechendes impfstoff

Info

Publication number
ATE270707T1
ATE270707T1 AT00988869T AT00988869T ATE270707T1 AT E270707 T1 ATE270707 T1 AT E270707T1 AT 00988869 T AT00988869 T AT 00988869T AT 00988869 T AT00988869 T AT 00988869T AT E270707 T1 ATE270707 T1 AT E270707T1
Authority
AT
Austria
Prior art keywords
entepneumovirus
corresponding vaccine
avian
vaccine
pneumovirosis
Prior art date
Application number
AT00988869T
Other languages
English (en)
Inventor
Sylvain Gabriel Goutebroze
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE270707T1 publication Critical patent/ATE270707T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Loading And Unloading Of Fuel Tanks Or Ships (AREA)
  • Peptides Or Proteins (AREA)
AT00988869T 1999-11-26 2000-11-22 Entepneumovirus und entsprechendes impfstoff ATE270707T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914952A FR2801607B1 (fr) 1999-11-26 1999-11-26 Pneumovirus du canard et vaccins correspondants
PCT/FR2000/003255 WO2001038497A1 (fr) 1999-11-26 2000-11-22 Pneumovirus du canard et vaccins correspondants

Publications (1)

Publication Number Publication Date
ATE270707T1 true ATE270707T1 (de) 2004-07-15

Family

ID=9552613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00988869T ATE270707T1 (de) 1999-11-26 2000-11-22 Entepneumovirus und entsprechendes impfstoff

Country Status (6)

Country Link
US (1) US6919084B2 (de)
EP (1) EP1232249B1 (de)
AT (1) ATE270707T1 (de)
DE (1) DE60012042T2 (de)
FR (1) FR2801607B1 (de)
WO (1) WO2001038497A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715922B2 (en) 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
DK1351981T3 (da) 2001-01-19 2012-11-26 Vironovative Bv Et virus, der forårsager luftvejssygdom hos modtagelige pattedyr
US20040005545A1 (en) 2002-02-21 2004-01-08 Fouchier Ronaldus Adrianus Maria Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine
CA2523319A1 (en) 2003-04-25 2004-11-11 Medimmune Vaccines, Inc. Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
US20060228367A1 (en) * 2005-04-08 2006-10-12 Medimmune, Inc. Antibodies against mammalian metapneumovirus
JPWO2007072916A1 (ja) * 2005-12-22 2009-06-04 財団法人化学及血清療法研究所 卵内接種用ワクチン
WO2010063033A2 (en) 2008-11-28 2010-06-03 Merial Limited Recombinant avian influenza vaccine and uses thereof
JP5797636B2 (ja) 2009-04-03 2015-10-21 メリアル リミテッド ニューカッスル病ウイルスをベクターとするトリワクチン
SG178523A1 (en) 2009-08-21 2012-03-29 Merial Ltd Recombinant avian paramyxovirus vaccine and method for making and using thereof
CA2785653C (en) 2009-12-28 2018-05-01 Merial Limited Recombinant ndv antigen and uses thereof
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
NZ702145A (en) 2010-03-12 2016-03-31 Merial Inc Bluetongue virus recombinant vaccines and uses thereof
CN103269714B (zh) 2010-08-31 2016-06-29 梅里亚有限公司 以新城疫病毒为载体的疱疹病毒疫苗
CN102166029A (zh) * 2011-05-05 2011-08-31 陈明科 一种仙草多菌养生精功能饮料
NZ618125A (en) 2011-05-27 2016-03-31 Merial Ltd Genetic vaccines against hendra virus and nipah virus
WO2013123219A1 (en) 2012-02-14 2013-08-22 Merial Limited Rotavirus subunit vaccines and methods of making and use thereof
ES2664069T3 (es) 2012-06-13 2018-04-18 Merial, Inc. Vacunas contra BTV y AHSV de genoma reordenado
KR20150110531A (ko) 2012-12-18 2015-10-02 메리얼 인코포레이티드 Ibv, csfv 및 ndv 의 고 해상도 용융 유전자형분석
BR112017027895A2 (pt) 2015-06-23 2018-11-06 Merial Inc vetores virais recombinantes contendo proteínas menores de prrsv e métodos de fabricação e utilização destes
PT3355915T (pt) 2015-09-29 2023-12-19 Boehringer Ingelheim Animal Health Usa Inc Vacinas de partículas pseudovirais (vlp) de parvovírus canino (cpv) e suas utilizações
US10780158B2 (en) 2015-11-16 2020-09-22 Georgia State University Research Foundation, Inc. Tunable vaccine platform against pathogens of the paramyxovirus family
NZ743236A (en) 2015-11-23 2019-12-20 Boehringer Ingelheim Animal Health Usa Inc Fmdv and e2 fusion proteins and uses thereof
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
US10485857B2 (en) 2016-04-07 2019-11-26 Boehringer Ingelheim Animal Health USA Inc. Heartworm vaccine, methods and uses thereof
CN107653231B (zh) * 2017-09-28 2021-02-23 河南科技学院 鸭源性冠状病毒弱毒株ibvdcv35及其应用
CN113384692A (zh) * 2020-12-28 2021-09-14 哈药集团生物疫苗有限公司 鸭呼肠弧病毒、鸭圆环病毒二联灭活疫苗及其制备方法
CN114209821A (zh) * 2021-12-30 2022-03-22 哈药集团生物疫苗有限公司 防治鸭圆环病毒病、新型鸭呼肠孤病毒病和鸭腺病毒病3型的三联灭活疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602791B1 (fr) * 1986-08-18 1988-11-10 Ministere Agri Direction Quali Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
ES2053732T3 (es) * 1987-05-21 1994-08-01 Know How Licensors Ltd Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
US6605460B1 (en) * 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine

Also Published As

Publication number Publication date
US20020192234A1 (en) 2002-12-19
EP1232249B1 (de) 2004-07-07
DE60012042D1 (de) 2004-08-12
WO2001038497A1 (fr) 2001-05-31
DE60012042T2 (de) 2005-07-07
US6919084B2 (en) 2005-07-19
EP1232249A1 (de) 2002-08-21
FR2801607A1 (fr) 2001-06-01
FR2801607B1 (fr) 2001-12-28

Similar Documents

Publication Publication Date Title
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
NO20015073L (no) Vaksiner
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
DE60012711D1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
NO20001768L (no) Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
AU2003235707A8 (en) Immunogenic preparations and vaccines on the basis of mrna
UY26555A1 (es) Composición farmacéutica para modulación inmunológica y preparación de vacunas
CY1107457T1 (el) Εμβoλιο κατa του hpv
NL300415I1 (nl) Vaccin tegen antigenen van bacteriën
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
CY1113826T1 (el) Ανοσοενισχυτικα για εμβολια
DK1079857T3 (da) Meningitidis B/C-kombinationsvacciner
DK1259259T3 (da) Mucosal adjuvansformulering
WO2003051392A3 (en) Streptococcus pneumoniae vaccine
WO2003063899A3 (en) Vaccine adjuvant based on a cd4 0 ligand
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
DE69826019D1 (de) Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung
WO2000061766A3 (en) Telomerase-specific cancer vaccine
WO2001022994A3 (en) Vaccines against neisseria infection
WO2005048918A3 (en) Anthrax vaccine
FR2796282B1 (fr) Vaccin inactive contre la calicivirose feline
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
WO2002070004A3 (en) Papillomavirus vaccines
DE60121035D1 (de) Impfstoff zur Behandung von Nikotinabhängigkeit
WO2002030458A8 (en) Yersinia adhesion protein as vaccine adjuvant

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties